Watkins R E, Wisely G B, Moore L B, Collins J L, Lambert M H, Williams S P, Willson T M, Kliewer S A, Redinbo M R
Department of Biochemistry and Biophysics, School of Medicine, University of North Carolina (UNC) at Chapel Hill, Chapel Hill, NC 27599, USA.
Science. 2001 Jun 22;292(5525):2329-33. doi: 10.1126/science.1060762. Epub 2001 Jun 14.
The human nuclear pregnane X receptor (hPXR) activates cytochrome P450-3A expression in response to a wide variety of xenobiotics and plays a critical role in mediating dangerous drug-drug interactions. We present the crystal structures of the ligand-binding domain of hPXR both alone and in complex with the cholesterol-lowering drug SR12813 at resolutions of 2.5 and 2.75 angstroms, respectively. The hydrophobic ligand-binding cavity of hPXR contains a small number of polar residues, permitting SR12813 to bind in three distinct orientations. The position and nature of these polar residues were found to be critical for establishing the precise pharmacologic activation profile of PXR. Our findings provide important insights into how hPXR detects xenobiotics and may prove useful in predicting and avoiding drug-drug interactions.
人类核孕烷X受体(hPXR)可响应多种异生素激活细胞色素P450 - 3A的表达,并在介导危险的药物相互作用中起关键作用。我们分别以2.5埃和2.75埃的分辨率展示了hPXR配体结合域单独以及与降胆固醇药物SR12813形成复合物时的晶体结构。hPXR的疏水配体结合腔含有少量极性残基,使得SR12813能够以三种不同的方向结合。发现这些极性残基的位置和性质对于确定PXR精确的药理学激活特征至关重要。我们的研究结果为hPXR如何检测异生素提供了重要见解,并可能有助于预测和避免药物相互作用。